2023-03-30T16:58:21+08:00 weekly 1.0 https://ja.prisysbiotech.com/ 2024-11-12T23:23:59+08:00 weekly 0.9 https://ja.prisysbiotech.com/animal-welfare 2024-11-12T23:23:57+08:00 weekly 0.9 https://ja.prisysbiotech.com/ophthalmic-disease-research 2024-11-13T00:20:15+08:00 weekly 0.9 https://ja.prisysbiotech.com/inflammation-immunology-disorders 2024-11-12T23:24:21+08:00 weekly 0.9 https://ja.prisysbiotech.com/respiratory-disease-research 2024-11-12T23:23:57+08:00 weekly 0.9 https://ja.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-12T23:23:56+08:00 weekly 0.9 https://ja.prisysbiotech.com/translational-research-center 2023-02-27T15:56:40+08:00 weekly 0.9 https://ja.prisysbiotech.com/co-develop 2024-11-12T23:23:57+08:00 weekly 0.9 https://ja.prisysbiotech.com/metabolic-syndromes-research 2024-11-12T23:23:48+08:00 weekly 0.9 https://ja.prisysbiotech.com/hematological-disease-research 2024-11-12T23:23:58+08:00 weekly 0.9 https://ja.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://ja.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://ja.prisysbiotech.com/fibrosis 2024-11-12T23:23:57+08:00 weekly 0.9 https://ja.prisysbiotech.com/about-us 2024-11-12T23:23:57+08:00 weekly 0.9 https://ja.prisysbiotech.com/contact-us 2023-03-31T10:52:07+08:00 weekly 0.9 https://ja.prisysbiotech.com/newslist-1 2024-11-12T23:23:56+08:00 weekly 0.9 https://ja.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://ja.prisysbiotech.com/blog/ 2023-03-31T10:33:18+08:00 weekly 1.0 https://ja.prisysbiotech.com/nhp-pharmacology/ 2023-03-31T10:33:18+08:00 weekly 0.9 https://ja.prisysbiotech.com/safety-evaluation/ 2023-03-31T10:33:18+08:00 weekly 0.9 https://ja.prisysbiotech.com/translation-research/ 2023-03-31T10:33:18+08:00 weekly 0.9 https://ja.prisysbiotech.com/biosafety-research/ 2023-03-31T10:33:19+08:00 weekly 0.9 https://ja.prisysbiotech.com/pk-pd-adme/ 2024-04-10T12:19:33+08:00 weekly 0.9 https://ja.prisysbiotech.com/clearpoint/ 2023-03-31T10:52:21+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-12T23:24:10+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-31T10:52:21+08:00 weekly 0.8 https://ja.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-12T23:23:52+08:00 weekly 0.8 https://ja.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-12T23:23:56+08:00 weekly 0.8 https://ja.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-12T23:50:10+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-12T23:23:48+08:00 weekly 0.8 https://ja.prisysbiotech.com/translation-research/nhpresources.html 2024-11-12T23:50:13+08:00 weekly 0.8 https://ja.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-12T23:24:11+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-12T23:23:49+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-12T23:23:54+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-12T23:23:49+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-31T10:52:25+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-31T10:52:23+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-31T10:52:23+08:00 weekly 0.8 https://ja.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-31T10:52:25+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-12T23:23:50+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-12T23:23:45+08:00 weekly 0.8 https://ja.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-12T23:23:49+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-31T10:52:23+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-12T23:23:56+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-31T10:52:23+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-03-31T10:52:23+08:00 weekly 0.8 https://ja.prisysbiotech.com/translation-research/translational-studies.html 2023-03-31T10:52:24+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-31T10:52:27+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-12T23:23:53+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-03-31T10:52:26+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-12T23:23:52+08:00 weekly 0.8 https://ja.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-31T10:52:27+08:00 weekly 0.8 https://ja.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-12T23:23:48+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-12T23:23:56+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ja.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-12T23:23:49+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-12T23:24:01+08:00 weekly 0.8 https://ja.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-12T23:24:01+08:00 weekly 0.8 https://ja.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-12T23:23:59+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-12T23:24:06+08:00 weekly 0.8 https://ja.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-26T14:15:14+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T14:15:18+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-26T14:15:19+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-26T14:15:21+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-26T14:15:23+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-26T14:15:26+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-11-12T23:23:58+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-12-04T13:06:36+08:00 weekly 0.8 https://ja.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-04T13:06:39+08:00 weekly 0.8 https://ja.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-02T02:59:33+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-02T02:59:33+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-12T20:39:28+08:00 weekly 0.8 https://ja.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-07-12T21:17:46+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-08-20T00:30:58+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-13T18:29:38+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T04:27:15+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-24T22:27:48+08:00 weekly 0.8 https://ja.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-29T15:41:57+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T11:28:36+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T18:40:59+08:00 weekly 0.8 https://ja.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-03-31T10:52:18+08:00 weekly 0.9 https://ja.prisysbiotech.com/newslist-713608-1 2023-03-31T10:52:18+08:00 weekly 0.9 https://ja.prisysbiotech.com/newslist-713609-1 2024-07-29T16:32:36+08:00 weekly 0.9 https://ja.prisysbiotech.com/newslist-818683-1 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/meetprisys-sot2023-66085938.html 2023-03-31T10:52:20+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-sot2023-66085939.html 2023-03-31T10:52:19+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66085940.html 2023-03-31T10:52:21+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66085941.html 2023-03-31T10:52:21+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/gene-therapy-nhp-model-66085942.html 2023-03-31T10:52:24+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66085943.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66085944.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66085945.html 2023-03-31T10:52:25+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66085947.html 2023-03-31T10:52:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66085988.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/gene-therapy-toxicology-66267819.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67241034.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67241035.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/world-parkinsons-disease-day-67241036.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67241037.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67241038.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67241039.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67241040.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67241041.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68102991.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68102992.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68102993.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68106064.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68308222.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-68995851.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-68996299.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-68996300.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-68996440.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-68997513.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-68999188.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309289.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309301.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309303.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309346.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69653957.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69656845.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70941431.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/0-70941434.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70941435.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70941436.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70941443.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70941450.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321219.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321220.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321221.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321222.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321223.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72674158.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001108.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73525997.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73525998.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74123009.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654589.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74782916.html 2024-11-12T23:23:51+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75160771.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75160772.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76173572.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77051995.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77698372.html 2024-11-12T23:23:50+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77698392.html 2024-11-12T23:23:59+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79187813.html 2024-11-12T23:23:58+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79187815.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79187816.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-asthma-model-79187817.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79187840.html 2024-11-12T23:24:09+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410698.html 2024-11-12T23:23:59+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410699.html 2024-11-12T23:24:08+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410700.html 2024-11-12T23:23:58+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pk-strategies-of-pdc-79527615.html 2024-11-12T23:23:52+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79527618.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79527619.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79527620.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79527621.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527622.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79527623.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79527624.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79527625.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79527626.html 2024-11-12T23:23:55+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79527628.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79527629.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527630.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79527631.html 2024-11-12T23:23:56+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79527632.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79527633.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527634.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527635.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79527636.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79527637.html 2024-11-12T23:23:55+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527638.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527639.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527640.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79527642.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79527643.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527644.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527645.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79527646.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527647.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527649.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527650.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527651.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527652.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527654.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/mrna-based-therapies-present-79527655.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79527656.html 2024-11-12T23:23:53+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/mrna-based-therapies-past-79527657.html 2024-11-12T23:23:55+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527658.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527659.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527660.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527661.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79527662.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527663.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/significance-principles-and-requirements-of-79527665.html 2024-11-12T23:23:53+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79528393.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79528395.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79528398.html 2024-08-07T08:44:35+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656482.html 2024-11-12T23:23:55+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/convection-enhanced-delivery-81120589.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120590.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120591.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/animal-models-of-human-diseases-81120592.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120593.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/china-experimental-monkey-industry-81120594.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120595.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120596.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120598.html 2024-11-12T23:23:57+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120600.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/human-disease-animal-models-81120602.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/compartment-pk-model-81120603.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81121001.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82374895.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82653635.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82653636.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82653637.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82653639.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82653640.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82653641.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82653643.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82653646.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82653658.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-82980892.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-82980896.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-82980901.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84007093.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84007094.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84007095.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84007096.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84007097.html 2025-01-19T08:52:43+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84007098.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84007102.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84007103.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84008491.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244147024897024.html 2025-02-27T02:49:09+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244147356574720.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295703473431552.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295703480116224.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295703482426368.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/animal-models-for-womens-health-17295703554630656.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295703568294912.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295703576404992.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295703585055744.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/membranous-nephropathy-model-17295703597081600.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295703753761792.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295703773012992.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295703780467712.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295703782384640.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295703828210688.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295703828227072.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295703876674560.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295703899235328.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295736578450432.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299782398764032.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374316669559808.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374316694791168.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374316749284352.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374316758590464.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374316772664320.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374316800238592.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374316866888704.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374316923741184.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374316930753536.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374317113615360.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17380877979460608.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17380939354956800.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17439718921249792.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17439718965339136.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17439718978446336.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17439718980051968.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17439719015130112.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17439719029285888.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17439719075013632.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17439719190701056.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17439719199482880.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17439719208739840.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17439719231169536.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/key-considerations-for-dosing-volume-17439757098214400.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17493738120979456.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17493738167395328.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17493738225673216.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17493738228491264.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17493738266010624.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-copd-model-17493738346456064.html 2025-09-13T18:29:46+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/brain-targeted-drug-delivery-17528751041586176.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17528772539491328.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/the-importance-of-administration-volume-17528772563313664.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17528772666139648.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17528772678001664.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17528772678018048.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17528772896154624.html 2025-09-20T04:27:22+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537834598867968.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551257318122496.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625013646271488.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625013734040576.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625013799609344.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625013912871936.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625013947507712.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625013970166784.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625014052709376.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-renal-biopsy-17625014095930368.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625014114362368.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625014887998464.html 2026-04-07T21:23:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625015521993728.html 2025-12-25T11:28:28+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674141078627328.html 2025-12-25T11:28:31+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674141099877376.html 2025-12-25T11:28:30+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674141114491904.html 2025-12-25T11:28:45+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674141133480960.html 2025-12-25T11:28:44+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674141140280320.html 2025-12-25T11:28:48+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674141145408512.html 2025-12-25T11:28:48+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674141157516288.html 2025-12-25T11:28:38+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674141225575424.html 2025-12-25T11:28:38+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674141321700352.html 2026-01-29T18:24:05+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724106567132160.html 2026-01-29T18:24:21+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724106637075456.html 2026-01-29T18:24:05+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724106676134912.html 2026-01-29T18:24:03+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724106742014976.html 2026-01-29T18:24:19+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724106827097088.html 2026-01-29T18:24:30+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724106836845568.html 2026-01-29T18:24:01+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724106856801280.html 2026-01-29T18:40:54+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724116562158592.html 2026-01-29T18:40:55+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724116589945856.html 2026-01-29T18:41:02+08:00 weekly 0.8 https://ja.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724116660970496.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://ja.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://ja.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://ja.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://ja.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://ja.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://ja.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html